Introduction {#s1}
============

Kashin--Beck Disease (KBD) is named after the two Russian Cossack doctors Nikolai Kashin and Evgeny Beck who first described bone deformities in patients in Russia in 1848 and 1906, respectively [@pone.0071411-Stone1]. Today, KBD is known as an endemic, chronic, and degenerative osteoarthropathy, with the involvement of epiphyseal cartilage damage, joint damage, and gradual deformation of the bone and joints [@pone.0071411-Kolsteren1]--[@pone.0071411-Pasteels1]. KBD is endemic in a crescent-shaped area encompassing South-Eastern Siberia to North China, Central China, and Chinese Tibet; it is also endemic in Mongolia and North Korea [@pone.0071411-Hinsenkamp1]. China has the most KBD patients in the world [@pone.0071411-Stone1]. The most frequently involved joints are the ankles, knees, wrists, and elbows. The disease often occurs in children aged 5--15 years and is age related, and serious KBD is responsible for significant disability. In some KBD endemic regions in China, the incidence of KBD is about 8.3% (2.5 million of 30 million urban residents affected) [@pone.0071411-Zhang1].

The etiology of KBD is largely unknown. The risk factors are thought to include deficiency in trace elements, mainly selenium and iodine deficiency [@pone.0071411-MorenoReyes1]--[@pone.0071411-FairweatherTait1]. In addition, mycotoxins such as Trichothecene mycotoxin (T-2), which are produced by various fungi such as *F. compactum*, *F. moniliforme*, and *F. oxysporum* in contaminated storage grains, are also suspected factors in KBD susceptibility [@pone.0071411-Marasas1]--[@pone.0071411-Chasseur1]. Organic substances such as humic acid and fulvic acid in drinking water have also been implicated in the disease [@pone.0071411-Peng1], [@pone.0071411-Ying1], [@pone.0071411-Li1]. Among all of these risk factors, selenium and iodine have been extensively studied. Recently we also confirmed that low selenium and iodine concentrations are associated with KBD [@pone.0071411-Shi1].

Genetic factors also play an important role in the pathogenesis of KBD. Xiong *et al*. showed that the polymorphisms of the selenoprotein *GPX1* gene (rs1050450 and Pro200Leu) were significantly different between patients with KBD and controls (*P* = 0.013) in a Han Chinese population [@pone.0071411-Xiong1]. To further investigate the potential relationship between selenoprotein genes and KBD susceptibility in Tibetans, we analyzed the association of the three selenoprotein genes *GPX1* (rs1050450, rs1800668, and rs3811699), *TrxR2* (rs5748469), and *DIO2* (rs225014) with Tibetan KBD in this study. Moreover, we investigated the association between these SNPs and serum selenium and iodine concentrations in Tibetans.

Materials and Methods {#s2}
=====================

Study population {#s2a}
----------------

KBD patients and matched normal controls in this study were recruited from Tibetan populations in the same endemic villages in Song Pan, Ruo Er Gai, and Hong Yuan counties in the Aba Tibetan Autonomous prefecture of Sichuan Province, China. Clinical examination was performed as the methods of Moreno-Reyes [@pone.0071411-MorenoReyes1] and Greulich [@pone.0071411-GreulichWW1]. Patients show joint of fingers, toes, knees and ankles swelling ([Figure 1](#pone-0071411-g001){ref-type="fig"}). The KBD patients showed specific changes on X-ray photography; they did not have other arthritis diseases such as rheumatoid arthritis (RA), Osteoarthritis (OA), or local inflammation. Normal controls were individuals with a normal joint examination and no other bone or joint disease. Clinical information about the patients and the controls is listed in [Table 1](#pone-0071411-t001){ref-type="table"}. Veinal bloods (5 ml) of the participants were collected for DNA extraction. The Institutional Review Boards of the Sichuan Academy of Medical Sciences & Sichuan Provincial People\'s Hospital approved this study. All of the participants received and signed the informed consent.

![Clinical features of KBD patients.\
A. A female KBD patient with her knee, ankle and toe joints deformity, the arrows show multiple joints of this patient are affected. B. A male KBD patient with his fingers joints deformity. C. The X-ray picture of a KBD patient\'s hand.](pone.0071411.g001){#pone-0071411-g001}

10.1371/journal.pone.0071411.t001

###### Characteristics of the KBD cases and controls.

![](pone.0071411.t001){#pone-0071411-t001-1}

  Characteristics     Cases(n = 638)   Controls(n = 324)
  ------------------ ---------------- -------------------
  Age, mean ± SD        53.3±13.07        54.5±15.81
  Sex, male/female       244/394            157/167
  Degree                              
  I                        241                --
  II                       336                --
  III                       60                --
  IV                        1                 --

Selection of SNPs {#s2b}
-----------------

Following a review of the literature, we selected five single nucleotide polymorphisms (SNPs) in three selenoprotein genes to genotype: *glutathione peroxidase 1* (*GPX1*, rs1050450), thioredoxin reductase 2 (*TrxR2*, rs5748469), and iodothyronine deiodinase type 2 (*DIO2*, rs225014) to genotype [@pone.0071411-Xiong1]. We also referenced the NCBI SNP database and selected rs1800668 and rs3811699 in the *GPX1* gene for genotyping. Information pertaining to the five SNPs selected is shown in [Table 2](#pone-0071411-t002){ref-type="table"}.

10.1371/journal.pone.0071411.t002

###### Conditions used for genotyping assays.
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  SNPs                                                                      Primers                                  Ta(°C)
  ------------------------------------------ ---------------------------------------------------------------------- --------
  GPX1(rs1050450)                                                   FW:CGCCAAGAACGAAGAGATTC                            58
  missense CCC⇒ CTC Pro200Leu                                       RV:CTGACACCCGGCACTTTATT                         
                                                             S30-C/T:CTGACATCGAAGCCCTGCTGTCTCAAGGGC                 
                                                       SV40-A/G:CCAAGCAGCCGGGGTAGGAGGGGCGCCCTAGGCACAGCTG            
  GPX1(rs1800668)                                                   FW:ACAGGAGAGGAGGGCTGTTT                           63.5
  UTR-5 C/T                                                         RV:AGAAGGCATACACCGACTGG                         
                                              S60-C/T:CCTGTGCCACGTGACCCGCCGCCGGCCAGTTAAAAGGAGGCGCCTGCTGGCCTCCCCTTA  
  GPX1(rs3811699)                                                   FW:AGGACTTCCTGGCCTAGCTC                           63.3
  nearGene-5 C/T                                                    RV:CCAGAGGGATCTAGGCTTCC                         
                                                   S50C/T:GCCAAGGAAACGCTGCCGGAGTCCTCCCTCCCTGGCCTCCTCAGGCTGCA        
  DIO2(rs225014)                                                     FW:TCGTGAAAGGAGGTCAAGT                            58
  missense C/T ACA⇒ GCA Thr92Ala;Thr128Ala                          RV:GTGGCAATGTGTTTAATGTG                         
                                                   S50-C/T:CTCAGCTATCTTCTCCTGGGTACCATTGCCACTGTTGTCACCTCCTTCTG       
  TrxR2(rs5748469)                                                   FW:TCCCAAAGTGCTGTGAGT                             58
  missense A/C GCC⇒ TCC Ala66Ser                                     RV:ACCTGCTGCTCTCCTTATC                         
                                                        S40-A/C:TGCCTACCTTGGGGAGAAGGTTCCACGTAGTCCACCACGG            

Genotyping {#s2c}
----------

Genomic DNA was extracted using a Gentra Puregene Blood DNA kit (Minneapolis, MN). SNP genotyping was performed by the dye terminator-based SNaPshot method (Applied Biosystems, Foster City, CA). The SNP analysis was performed on the ABI 3130XL genetic analyzer (Applied Biosystems). The genotypes of the SNPs were determined by Genemapper software (Applied Biosystems). All of the SNPs reported in this manuscript had a genotyping success rate \>96 percent and accuracy as judged by random regenotyping of 10 percent of the samples in the subject group. The PCR and SNaPshot primers are listed in [Table 2](#pone-0071411-t002){ref-type="table"}.

Statistical analysis {#s2d}
--------------------

The Hardy-Weinberg equilibrium (HWE) for each SNP polymorphism was tested by the χ2 test with df  = 1. The *P* values of the SNPs were calculated using an additive model. Unadjusted odds ratios of the alleles and genotypes were estimated by the χ2 test. The LD block structure was examined by using software Haploview Vision 4.2. The D and r2 values for all pairs of SNPs were calculated, and the haplotype blocks were estimated by using software Haploview Vision 4.2.All of the statistical analyses were performed using the software SPSS version 10.0. *P*\<0.05 was considered statistically significant.

Results {#s3}
=======

Genotype analysis of the KBD group and the controls {#s3a}
---------------------------------------------------

All of the five SNPs selected were successfully genotyped. However, the results showed that none of these five SNPs were significantly associated with KBD ([Table 3](#pone-0071411-t003){ref-type="table"}). Although the SNP rs1050450 (Pro200Leu) in the *GPX1* gene was reported to be significantly associated with KBD in previous studies in a Han Chinese population (*P* = 0.013), this SNP did not show a significant association with KBD in the Tibetan population in this study (*P* =  0.1031) [@pone.0071411-Xiong1]. The other two SNPs in the *GPX1* gene (rs1800668 at 5′UTR of the gene and rs3811699 at 3′upstream of the gene) also showed no association with KBD (*P* = 0.7614 and *P* = 0.8351, respectively). In contrast to the results that Xiong *et al*. reported in the Han population, neither the *DIO2* gene (rs225014) nor the *TrxR2* gene (rs5748469) showed significant differences in the Tibetan KBD group compared with the control group (*P* = 0.7287 and *P* = 0.4426, respectively).

10.1371/journal.pone.0071411.t003

###### Genotype and allele frequencies of polymorphisms across selenoprotein genes in Tibetan.
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  SNPs                Controls    KBD     Trend          
  ------------------ ---------- -------- ------- ------- --------------
  GPX1(rs1050450)                                         0.1031(0.74)
  CC                    271      0.836     559    0.876  
  CT                     53      0.164     79     0.124  
  TT                     0         0        0       0    
  C-allele              595      0.918    1197    0.938  
  T-allele               53      0.082      7     0.062  
  *P_HWE*              0.1089    0.0956                  
  GPX1(rs1800668)                                         0.7614(1.06)
  CC                    183      0.806     197    0.804  
  CT                     40      0.176     41     0.167  
  TT                     4       0.018      7     0.029  
  C-allele              406      0.894     435    0.883  
  T-allele               48      0.106     55     0.112  
  *P_HWE*              0.3046    0.012                   
  GPX1(rs3811699)                                         0.8351(0.95)
  TT                    202      0.838     212    0.841  
  CT                     35      0.145     37     0.147  
  CC                     4       0.017      3     0.012  
  T-allele              439      0.911     461    0.915  
  C-allele               43      0.089     43     0.085  
  *P_HWE*              0.0988    0.3467                  
  DIO2(rs225014)                                          0.7287(1.04)
  TT                     94      0.388     158    0.356  
  CT                    113      0.467     228    0.514  
  CC                     35      0.145     58     0.131  
  T-allele              301      0.622     544    0.613  
  C-allele              183      0.378     344    0.387  
  *P_HWE*              0.9121    0.0844                  
  TrxR2(rs5748469)                                        0.4426(0.86)
  AA                    137      0.714     209    0.749  
  AC                     50       0.26     63     0.226  
  CC                     5       0.026      7     0.025  
  A-allele              324      0.844     481    0.882  
  C-allele               60      0.156     77     0.138  
  *P_HWE*              0.8642    0.3958                  

Haplotype analysis of the three SNPs in the *GPX1* gene {#s3b}
-------------------------------------------------------

We examined the three SNPs in gene *GPX1* (rs3811699, rs1050450, and rs1800668) in all tested samples using the program Haploview (Vision4.2). The haplotypes TCC, TTC and TTT generated from these three SNPs proved to be significantly different between the KBD cases and controls (*P* = 0.0421, 0.0005 and 0.0066, [Table 4](#pone-0071411-t004){ref-type="table"}). These individuals showed protective feature in the susceptibility of KBD with the odds ratios of 0.69, 0.22 and 0.15 respectively.

10.1371/journal.pone.0071411.t004

###### The haplotype association of *gpx1* with KBD in this study.
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  Haplotype    Frequencies   Chi Square   P value    Odds ratio (95% CI)
  ----------- ------------- ------------ ---------- ---------------------
  TCC             0.848        4.132       0.0421     0.69(0.49--0.98)
  CTT             0.06         0.222       0.6376     1.14(0.67--1.91)
  TTC             0.032        12.183     5.00E-04   0.22(0.088--0.553)
  CCT             0.022        0.436       0.5092     1.34(0.57--3.14)
  TCT             0.016        0.296       0.5861     1.32(0.49--3.57)
  TTT             0.015        7.371       0.0066     0.15(0.03--0.724)

Comparison of the Results of the Genotype Analysis Based on the Subjects\' Iodine or Selenium Concentrations {#s3c}
------------------------------------------------------------------------------------------------------------

Given that KBD is related to iodine or selenium deficiency, we analyzed the genotypes of the KBD group and the controls in relation to the subjects\' serum iodine or selenium concentrations which were tested previously [@pone.0071411-Shi2]. The results are shown in [Table 5](#pone-0071411-t005){ref-type="table"} and [Table 6](#pone-0071411-t006){ref-type="table"} for iodine and selenium, respectively. We found no significant differences between the KBD group and the controls, providing additional evidence for the absence of an association between the five SNPs and KBD in the Tibetan population. The power calculation results are shown in [Table 7](#pone-0071411-t007){ref-type="table"}.

10.1371/journal.pone.0071411.t005

###### Genotype and allele frequencies of polymorphisms across selenoprotein genes by serum iodine concentration in Tibetan population.

![](pone.0071411.t005){#pone-0071411-t005-5}

  SNPs                Controls   KBD   Controls    KBD     Trend    Higher group   Lower group   Higher group   Lower group     Trend
  ------------------ ---------- ----- ---------- -------- -------- -------------- ------------- -------------- ------------- -----------
  GPX1(rs1050450)                                          0.9129                                                             \*0.02726
  CC                    146      155    0.811     0.816                 154            147           0.77          0.865     
  CT                     34      35     0.189     0.184                  46            23            0.23          0.135     
  TT                     0        0       0         0                    0              0             0              0       
  C-allele              326      345    0.906     0.908                 354            317          0.885          0.932     
  T-allele               34      35     0.094     0.092                  46            23           0.115          0.068     
  *P_HWE*                               0.1617    0.162                0.0661                      0.14013        0.3441     
  GPX1(rs1800668)                                          0.1401                                                              0.3982
  CC                    205      207    0.804     0.881                 187            181          0.379          0.823     
  CT                     49      22     0.192     0.094                  48            33            0.2           0.15      
  TT                     1        6     0.004     0.026                  5              6           0.021          0.027     
  C-allele              459      436     0.9      0.928                 422            395          0.879          0.898     
  T-allele               51      34      0.1      0.072                  58            45           0.121          0.102     
  *P_HWE*                               0.2808      0                                               0.3634        0.0066     
  GPX1(rs3811699)                                          0.8763                                                              0.14013
  TT                    200      212     0.84     0.841                 205            207          0.804          0.881     
  CT                     34      37     0.143     0.147                  49            22           0.192          0.094     
  CC                     4        3     0.017     0.012                  1              6           0.004          0.026     
  T-allele              434      461    0.912     0.915                 459            436           0.9           0.928     
  C-allele               42      43     0.088     0.085                  51            34            0.1           0.072     
  *P_HWE*                              0.08364    0.3467                                            0.2808           0       
  DIO2(rs225014)                                           0.6574                                                              0.4836
  TT                    170      175     0.73     0.742                  70            81           0.348          0.382     
  CT                     56      56      0.24     0.237                 105            106          0.522           0.5      
  CC                     7        5      0.03     0.021                  26            25           0.129          0.118     
  T-allele              396      406     0.85      0.86                 245            268          0.609          0.632     
  C-allele               70      66      0.15      0.14                 157            158          0.391          0.368     
  *P_HWE*                               0.3712    0.8347                                           0.16748        0.2748     
  TrxR2(rs5748469)                                         0.4689                                                              0.6574
  AA                    136      209    0.716     0.749                 170            175           0.73          0.742     
  AC                     49      63     0.258     0.226                  56            56            0.24          0.237     
  CC                     5        7     0.026     0.025                  7              5            0.03          0.021     
  A-allele              321      481    0.845     0.862                 396            406           0.85          0.86      
  C-allele               59      77     0.155     0.138                  70            66            0.15          0.14      
  *P_HWE*                               0.8164    0.3958                                            0.3712        0.8347     

10.1371/journal.pone.0071411.t006

###### Genotype and allele frequencies of polymorphisms across selenoprotein genes by serum selenium concentration in Tibetan population.
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  SNPs                Controls   KBD   Controls    KBD     Trend   Higher group   Lower group   Higher group   Lower group   Trend
  ------------------ ---------- ----- ---------- -------- ------- -------------- ------------- -------------- ------------- --------
  GPX1(rs1050450)                                          0.932                                                             0.2849
  CC                    147      155    0.812     0.816                174            125          0.798          0.839     
  CT                     34      35     0.188     0.184                 44            24           0.202          0.161     
  TT                     0        0       0         0                   0              0             0              0       
  C-allele              328      345    0.906     0.908                392            274          0.899          0.919     
  T-allele               34      35     0.094     0.092                 44            24           0.101          0.081     
  *P_HWE*                               0.1631    0.162                                            0.2849        0.0975     
  GPX1(rs1800668)                                          0.701                                                             0.924
  CC                    182      197    0.809     0.804                173            206          0.797          0.811     
  CT                     39      41     0.173     0.167                 41            40           0.189          0.157     
  TT                     4        7     0.018     0.029                 3              8           0.014          0.031     
  C-allele              403      435    0.896     0.888                387            452          0.892          0.89      
  T-allele               47      55     0.104     0.112                 47            56           0.108          0.11      
  *P_HWE*                               0.2706    0.0121                                           0.749          0.002     
  GPX1(rs3811699)                                          0.887                                                             0.8969
  TT                    201      212    0.841     0.841                185            228          0.833          0.848     
  CT                     34      37     0.142     0.147                 35            36           0.158          0.134     
  CC                     4        3     0.017     0.012                 2              5           0.009          0.019     
  T-allele              436      461    0.912     0.915                405            492          0.912          0.914     
  C-allele               42      43     0.088     0.085                 39            46           0.088          0.086     
  *P_HWE*                               0.082     0.347                                            0.018         0.8099     
  DIO2(rs225014)                                           0.19                                                              0.6357
  TT                     57      94     0.425     0.337                 63            88           0.389          0.351     
  CT                     61      150    0.455     0.538                 72            139          0.444          0.554     
  CC                     16      35     0.119     0.125                 27            24           0.167          0.096     
  T-allele              175      338    0.653     0.606                198            315          0.611          0.627     
  C-allele               93      220    0.347     0.394                126            502          0.389          0.373     
  *P_HWE*                               0.9585    0.0359                                           0.0035        0.4085     
  TrxR2(rs5748469)                                         0.461                                                             0.6092
  AA                    136      209    0.716     0.749                154            191          0.748          0.726     
  AC                     49      63     0.258     0.226                 47            65           0.228          0.247     
  CC                     5        7     0.026     0.025                 5              7           0.024          0.027     
  A-allele              321      481    0.845     0.862                355            447          0.862          0.85      
  C-allele               59      77     0.155     0.138                 57            79           0.138          0.15      
  *P_HWE*                               0.8164    0.3958                                           0.5367         0.606     

10.1371/journal.pone.0071411.t007

###### Statistical Power Calculations for a Paired t Test and Their Effect on Desired Sample Size.
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         iodine(case/control)   selenium(case/control)   iodine(high/low)   selenium(high/low)
  ----- ---------------------- ------------------------ ------------------ --------------------
  α              0.05                    0.05                  0.05                0.05
  1-β            0.8                     0.8                   0.8                 0.8
  n               90                     1337                   3                   56

α, (alpha)the threshold value below which statistical significance will be declared.

1-β, (one minus beta) the statistical power.

n, the sample size.

Comparison of the Results of the Genotype Analysis Based on the Higher and Lower Serum Iodine or Selenium Concentration Groups {#s3d}
------------------------------------------------------------------------------------------------------------------------------

To further investigate the association of the five SNPs with the serum iodine or selenium concentration, we analyzed the genotype of those in the higher group and lower group of serum iodine or selenium concentration in the Tibetan population (subjects combined the patients and the controls). The mean serum iodine concentration of the combined samples including both cases and controls was 37.33 μg/L. The mean serum iodine concentration of the combined samples including both cases and controls was 37.33 μg/L. The mean serum iodine concentration in the lower group was 24.35 μg/L and 51.64 μg/L in the higher group. The mean serum selenium concentration was 28.65 μg/L. In the lower group, it was 18.18 μg/L, and in the higher group it was 44.40μg/L. The results are presented in the right column of [Table 5](#pone-0071411-t005){ref-type="table"} and [Table 6](#pone-0071411-t006){ref-type="table"} for iodine and selenium, respectively. The power calculation results are shown in [Table 7](#pone-0071411-t007){ref-type="table"}. The *GPX1* gene (rs1050450) showed a potential significant association with the iodine concentration, with trend *p* value of 0.02726. However, rs1050450 was not associated with the selenium concentration (trend *p* value  = 0.2849). These might be because the sample size is two less than the power calculated number size 1337 ([Table 7](#pone-0071411-t007){ref-type="table"}). Other SNPs showed no significant association with either iodine or the selenium concentration.

Discussion {#s4}
==========

KBD is believed to be a complex disease involving genetic factors, as well as environmental factors such as selenium and iodine deficiency [@pone.0071411-Stone1]. Based on a candidate gene approach, Xiong *et al*. reported that SNP rs1050450 in the selenoprotein *Gpx1* gene was significantly associated with KBD in a Han Chinese population [@pone.0071411-Xiong1], potentially linked this genetic variant to selenium and iodine deficiency in patients. In China, Tibetans who live in the plateau region are one of the most susceptible populations to KBD. Thus, in this study, we examined the genotype of five selenoprotein SNPs including rs1050450, rs1800668, and rs3811699 in the *Gpx1*gene, rs225014 in the *Dio2* gene, and rs5748569 in the *TrxR2* gene in KBD patients and controls in a Tibetan population. Our results provided no support for any one of the five SNPs being significantly associated with KBD in the Tibetan population. However, haplotype analysis of SNPs rs1050450, rs1800668 and rs3811699 in *GPX1* gene showed a significant association of KBD. Our previous study indicated that the concentrations of serum selenium and iodine in KBD patients were significantly lower than that of controls living in the same village [@pone.0071411-Shi2], suggesting that genetic variants may affect selenium and/or iodine metabolism. In this study, by haplotype analysis, we found haplotypes TCC, TTC and TTT generated from three SNPs rs1050450, rs1800668, and rs3811699 of *gpx1* gene proved to be significantly associated with KBD and play a protective role from the disease. This is consistent with the fact that supplement of selenium is beneficial for KBD children [@pone.0071411-Zou1].

In this study, for the first time, we observed that the *GPX1* gene rs1050450 is significantly associated with the serum iodine concentration (*P* trend  = 0.027). The *GPX1* gene encodes a member of the glutathione peroxidase family; SNP rs1050450 in this gene is polymorphic at codon 200, resulting in either a proline or a leucine at that position. Previous studies have suggested that the GPX1-200Leu variant has about 10% lower GPX activity than the wild-type enzyme [@pone.0071411-RavnHaren1] and that the frequency of the Leu allele is strongly associated with the risk of cancer, such as lung cancer, breast cancer, meningioma, and prostate cancer [@pone.0071411-RaaschouNielsen1]--[@pone.0071411-Steinbrecher1]. In the present study, we observed that the frequency of the Leu allele of rs1050450 is associated with a relatively higher iodine concentration.

Iodine is an essential component of the hormones produced by the thyroid gland. Therefore, iodine is essential for mammalian life [@pone.0071411-Kohrle1]. In mammals, after iodine is absorbed and distributed in the serum, most of it will be transported by the sodium/iodide symporter (NIS) symporter into the thyrocyte where iodine is oxidated in a reaction catalyzed by the hemoprotein thyroid peroxidase (TPO) and then incorporated into the thyroglobulin molecule (Tg-I) [@pone.0071411-Kohrle1]--[@pone.0071411-Kohrle2] ([Fig. 2](#pone-0071411-g002){ref-type="fig"}). In this reaction, H2O2 is generated by the NADPH-dependent thyroxidase (ThOx) and is required as a substrate by TPO for the iodination in Tg. The thyroid hormones triiodothyronine (T3) and tetraiodothyronine (T4) are then released into the bloodstream. When the iodine supply is sufficient, this H2O2 generation is the limiting step for thyroid hormone synthesis. Therefore, if the KM of TPO for H2O2 is very high, the higher amounts of H2O2 are produced than be consumed by the iodination process [@pone.0071411-Forchhammer1], the more likely potentially exposing the thyroid gland to free radical damage can be produced. Thus, to prevent organ damage, H2O2, H2O2 should be reduced to H2O immediately after the iodination process. Several selenoproteins participate in the protection of thyrocytes and the prevention of damage to the thyroid gland of H2O2 by catalyzing glutathione and H2O2 to glutathione disulfide and H2O [@pone.0071411-Kohrle1]. Selenium-dependent *GPX* gene is one of the first and most important antioxidant enzymes identified in humans and one of only a few proteins known in higher vertebrates to contain selenocysteine. *GPX1* can remove H2O2 from many tissues and cells to decrease oxidative damage. By searching human genes\' expression data, we observed that *GPX1* is very highly expressed in thyroid tissue (<http://www.genecards.org/cgi-bin/carddisp.pl?gene=GPX1&search=GPX1>). This suggests that this gene is an important H2O2 remover in the thyroid gland. When iodine is deficient, the thyroid would increase the generation of H2O2 to maintain the balance of thyroid hormone synthesis. Therefore, the gland requires a higher level of GPX activity to clear the H2O2 and prevent H2O2-induced damage. In contrast, when iodine is sufficient, less H2O2 and GPX are needed to maintain the hormone balance. Thus, we suspect that the iodine concentration and *GPX1* genetic variant might have undergone adaptive evolution in the distant past.

![Iodine and GPXs involved in Thyroid Hormones Biosynthesis.\
The serum sodium iodide is transported into the thyrocyte and then iodine is incorporated into the thyroglobulin molecule (Tg) in a reaction catalyzed by the hemoprotein thyroid peroxidase (TPO). In this reaction, H~2~O~2~ generated by the NADPH-dependent thyroxidase (ThOx) is required as substrate by TPO for the iodination and coupling of tyrosyl residues in Tg. Then, thyroid hormones triiodothyronine (T3) and tetraiodothyronine (T4) are released into the bloodstream. H~2~O~2~ used in this reaction decreases the amount of H~2~O~2~ that would otherwise be available for damaging oxidation reactions. Selenium-dependent glutathione peroxidase 1 (*GPX 1*) and other GPX s remove H~2~O~2~ from the tissues, also decreasing oxidative damage. (Modified from: J. Köhrle *et al*. Selenium, the thyroid, and the endocrine system. Endocrine Reviews, December 2005, 26(7):944--984; Lyn Patrick, ND. Iodine: deficiency and therapeutic considerations. Alternative Medicine Review, 2008, 13(2):116--127).](pone.0071411.g002){#pone-0071411-g002}

The biosynthesis of selenoproteins is highly regulated by its upstream effectors [@pone.0071411-Bock1], [@pone.0071411-Forchhammer1] and by the supply of selenium, which acts as a substrate for the first step in the biosynthesis of Sec-containing proteins. Yet we found no association between the genetic variant Sec-containing coding gene *GPX1* and the selenium concentration in this study. This might because the variant of rs1050450 does not affect the yield of *GPX*, although it does affect the activity of *GPX1*. As the selenium concentration can affect the mole yield of Sec-containing GPX, it can, therefore, influence the activity of the enzymes. Thus, iodine deficiency increases H2O2 generation, whereas selenium deficiency decreases H2O2 disposal [@pone.0071411-Kohrle1]. This results in oxidative cell damage causing chronic inflammation or autoimmune diseases. This linkage may explain why selenium and iodine deficiency are associated with many diseases, such as KBD and other impaired immune function--related disease [@pone.0071411-FairweatherTait1], [@pone.0071411-Kohrle2].
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